| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.807 | |
| naphthalene metabolic process | GO:0018931 | 1 | 0.663 | |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.547 | |
| vitamin d3 metabolic process | GO:0070640 | 3 | 0.546 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.529 | |
| naphthalene containing compound metabolic process | GO:0090420 | 1 | 0.501 | |
| renal tubular secretion | GO:0097254 | 2 | 0.500 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.473 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.465 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.437 | |
| cellular alcohol metabolic process | GO:0044107 | 3 | 0.392 | |
| secondary alcohol metabolic process | GO:1902652 | 3 | 0.389 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.377 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.370 | |
| steroid metabolic process | GO:0008202 | 119 | 0.346 | |
| cellular response to cadmium ion | GO:0071276 | 3 | 0.343 | |
| calcitriol biosynthetic process from calciol | GO:0036378 | 3 | 0.317 | |
| amine metabolic process | GO:0009308 | 45 | 0.280 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.274 | |
| oxidation reduction process | GO:0055114 | 342 | 0.256 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.251 | |
| angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | GO:0001998 | 3 | 0.250 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.248 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.237 | |
| drug metabolic process | GO:0017144 | 4 | 0.230 | |
| positive regulation of steroid hormone secretion | GO:2000833 | 2 | 0.225 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.220 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.206 | Mouse |
| cellular alcohol biosynthetic process | GO:0044108 | 3 | 0.202 | |
| lipid catabolic process | GO:0016042 | 69 | 0.181 | |
| response to stilbenoid | GO:0035634 | 22 | 0.178 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.177 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.170 | |
| transmembrane transport | GO:0055085 | 412 | 0.169 | |
| short chain fatty acid catabolic process | GO:0019626 | 2 | 0.167 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.164 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.164 | |
| terpenoid metabolic process | GO:0006721 | 25 | 0.161 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.150 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.148 | |
| blood circulation | GO:0008015 | 195 | 0.142 | |
| response to metal ion | GO:0010038 | 47 | 0.137 | |
| tetrapyrrole metabolic process | GO:0033013 | 22 | 0.137 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.136 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.135 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.131 | |
| vitamin metabolic process | GO:0006766 | 23 | 0.131 | |
| isoprenoid metabolic process | GO:0006720 | 29 | 0.129 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.128 | |
| hormone metabolic process | GO:0042445 | 86 | 0.126 | Mouse |
| fat soluble vitamin metabolic process | GO:0006775 | 11 | 0.125 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.125 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.124 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.123 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.122 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.118 | |
| monocarboxylic acid catabolic process | GO:0072329 | 27 | 0.116 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.115 | |
| lipid transport | GO:0006869 | 98 | 0.115 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.114 | |
| oxidative demethylation | GO:0070989 | 1 | 0.113 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.113 | |
| drug catabolic process | GO:0042737 | 2 | 0.112 | |
| porphyrin containing compound metabolic process | GO:0006778 | 22 | 0.111 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.109 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.106 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.105 | |
| protein processing | GO:0016485 | 163 | 0.102 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.101 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.101 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.100 | |
| cation transport | GO:0006812 | 399 | 0.100 | Mouse |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.096 | |
| pigment metabolic process | GO:0042440 | 32 | 0.096 | |
| organic anion transport | GO:0015711 | 137 | 0.095 | |
| arachidonic acid metabolic process | GO:0019369 | 14 | 0.094 | |
| protein maturation | GO:0051604 | 176 | 0.092 | |
| regulation of estrogen secretion | GO:2000861 | 1 | 0.092 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.091 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.091 | |
| plasma lipoprotein particle remodeling | GO:0034369 | 6 | 0.090 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.090 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.089 | |
| cofactor transport | GO:0051181 | 4 | 0.087 | |
| positive regulation of estrogen secretion | GO:2000863 | 1 | 0.084 | |
| anion transport | GO:0006820 | 177 | 0.084 | |
| heme metabolic process | GO:0042168 | 16 | 0.084 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.081 | |
| organic acid transport | GO:0015849 | 101 | 0.080 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.072 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.070 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.069 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.069 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.068 | |
| linoleic acid metabolic process | GO:0043651 | 6 | 0.067 | |
| endothelial cell differentiation | GO:0045446 | 41 | 0.067 | |
| regulation of secretion | GO:0051046 | 274 | 0.067 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.066 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.066 | |
| regulation of protein processing | GO:0070613 | 96 | 0.065 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.064 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.064 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.063 | |
| wound healing | GO:0042060 | 157 | 0.062 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.062 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.062 | |
| unsaturated fatty acid metabolic process | GO:0033559 | 31 | 0.061 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.060 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.059 | Human Mouse |
| endocrine process | GO:0050886 | 39 | 0.059 | |
| hexose metabolic process | GO:0019318 | 98 | 0.059 | |
| positive regulation of activation of membrane attack complex | GO:0001970 | 2 | 0.058 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.058 | |
| fat cell differentiation | GO:0045444 | 160 | 0.058 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.058 | |
| regulation of cholesterol metabolic process | GO:0090181 | 14 | 0.057 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.057 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.056 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.056 | |
| long chain fatty acid metabolic process | GO:0001676 | 26 | 0.056 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.056 | |
| response to steroid hormone | GO:0048545 | 56 | 0.056 | |
| lipid localization | GO:0010876 | 126 | 0.055 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.055 | |
| negative regulation of iron ion transport | GO:0034757 | 1 | 0.055 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.055 | |
| gland development | GO:0048732 | 330 | 0.054 | |
| regulation of fatty acid oxidation | GO:0046320 | 10 | 0.054 | |
| response to acid chemical | GO:0001101 | 111 | 0.054 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.054 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.053 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.053 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.053 | |
| epithelium migration | GO:0090132 | 63 | 0.053 | |
| multicellular organism growth | GO:0035264 | 161 | 0.053 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.053 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.053 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.053 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.052 | |
| response to drug | GO:0042493 | 75 | 0.052 | |
| fatty acid catabolic process | GO:0009062 | 25 | 0.052 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.052 | |
| sterol metabolic process | GO:0016125 | 58 | 0.051 | |
| polyol metabolic process | GO:0019751 | 26 | 0.050 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.050 | |
| circulatory system process | GO:0003013 | 197 | 0.050 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.049 | |
| response to peptide | GO:1901652 | 136 | 0.049 | |
| response to insulin | GO:0032868 | 100 | 0.049 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.049 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.049 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.048 | |
| regulation of blood vessel size by renin angiotensin | GO:0002034 | 5 | 0.048 | |
| cell adhesion | GO:0007155 | 329 | 0.048 | Human |
| response to inorganic substance | GO:0010035 | 96 | 0.046 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.046 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.045 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.045 | |
| protein catabolic process | GO:0030163 | 221 | 0.044 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.044 | |
| coenzyme metabolic process | GO:0006732 | 52 | 0.044 | |
| protein glycosylation | GO:0006486 | 55 | 0.043 | |
| regulation of system process | GO:0044057 | 200 | 0.043 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.043 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.043 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.043 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.042 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.042 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.042 | |
| fatty acid derivative metabolic process | GO:1901568 | 33 | 0.042 | |
| regulation of phosphatidylinositol 3 kinase signaling | GO:0014066 | 30 | 0.041 | |
| inflammatory response | GO:0006954 | 244 | 0.041 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.041 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.041 | |
| glucose metabolic process | GO:0006006 | 92 | 0.040 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.040 | |
| fibrinolysis | GO:0042730 | 3 | 0.040 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.040 | |
| female meiosis chromosome segregation | GO:0016321 | 1 | 0.040 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.040 | |
| urogenital system development | GO:0001655 | 261 | 0.039 | |
| regulation of intestinal cholesterol absorption | GO:0030300 | 4 | 0.039 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.038 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.038 | |
| cellular amino acid catabolic process | GO:0009063 | 25 | 0.038 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.038 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.037 | |
| regulation of vitamin d biosynthetic process | GO:0060556 | 1 | 0.037 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.037 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.037 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.037 | |
| hormone secretion | GO:0046879 | 128 | 0.037 | |
| synaptic transmission | GO:0007268 | 329 | 0.036 | |
| response to transition metal nanoparticle | GO:1990267 | 11 | 0.036 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.036 | |
| renal system process | GO:0003014 | 48 | 0.036 | |
| one carbon metabolic process | GO:0006730 | 1 | 0.036 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.036 | |
| cellular response to peptide | GO:1901653 | 92 | 0.036 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.036 | |
| estrogen secretion | GO:0035937 | 1 | 0.035 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.035 | |
| exocytosis | GO:0006887 | 121 | 0.035 | |
| diterpenoid metabolic process | GO:0016101 | 24 | 0.034 | |
| gluconeogenesis | GO:0006094 | 39 | 0.034 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.034 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.034 | |
| cellular response to lipid | GO:0071396 | 145 | 0.033 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.033 | |
| cellular response to metal ion | GO:0071248 | 31 | 0.033 | |
| icosanoid metabolic process | GO:0006690 | 33 | 0.033 | |
| response to nutrient levels | GO:0031667 | 109 | 0.033 | |
| angiogenesis | GO:0001525 | 201 | 0.033 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.033 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.033 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.032 | |
| vitamin a metabolic process | GO:0006776 | 2 | 0.032 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.032 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.032 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.032 | |
| positive regulation of lipid transport | GO:0032370 | 22 | 0.032 | |
| dibenzo p dioxin metabolic process | GO:0018894 | 1 | 0.031 | |
| sterol homeostasis | GO:0055092 | 45 | 0.030 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.030 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.030 | |
| response to peptide hormone | GO:0043434 | 127 | 0.030 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.030 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.030 | |
| monocarboxylic acid transport | GO:0015718 | 44 | 0.030 | |
| negative regulation of fibrinolysis | GO:0051918 | 1 | 0.030 | |
| cellular biogenic amine metabolic process | GO:0006576 | 28 | 0.030 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.030 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.029 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.029 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.029 | |
| response to oxidative stress | GO:0006979 | 123 | 0.029 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.029 | |
| artery development | GO:0060840 | 53 | 0.029 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.029 | |
| glycosylation | GO:0070085 | 62 | 0.029 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.028 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.028 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.028 | |
| lipid modification | GO:0030258 | 65 | 0.028 | |
| cellular homeostasis | GO:0019725 | 240 | 0.028 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.027 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.027 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.027 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.027 | |
| endothelial cell development | GO:0001885 | 20 | 0.027 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.027 | |
| fatty acid transport | GO:0015908 | 28 | 0.027 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.027 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.026 | |
| skeletal system development | GO:0001501 | 356 | 0.026 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.026 | |
| vitamin biosynthetic process | GO:0009110 | 7 | 0.026 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.025 | |
| positive regulation of blood pressure | GO:0045777 | 21 | 0.025 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.025 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.025 | |
| lipid homeostasis | GO:0055088 | 63 | 0.025 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.025 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.025 | |
| regulation of endocrine process | GO:0044060 | 13 | 0.025 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.025 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.024 | |
| cholesterol transport | GO:0030301 | 38 | 0.024 | |
| glycogen metabolic process | GO:0005977 | 32 | 0.024 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.024 | Mouse |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.024 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.024 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.024 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.024 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.024 | |
| regulation of tube size | GO:0035150 | 57 | 0.023 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.023 | Mouse |
| body fluid secretion | GO:0007589 | 53 | 0.023 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.023 | |
| ovarian follicle rupture | GO:0001543 | 2 | 0.023 | |
| activation of membrane attack complex | GO:0001905 | 4 | 0.023 | |
| renal system development | GO:0072001 | 225 | 0.023 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.023 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.023 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.023 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.023 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.023 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.023 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.023 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.023 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.022 | |
| cellular polysaccharide metabolic process | GO:0044264 | 38 | 0.022 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.022 | |
| tissue remodeling | GO:0048771 | 102 | 0.022 | |
| negative regulation of serine type endopeptidase activity | GO:1900004 | 2 | 0.022 | |
| positive regulation of fat cell differentiation | GO:0045600 | 32 | 0.022 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.022 | |
| respiratory tube development | GO:0030323 | 167 | 0.022 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.022 | |
| response to cadmium ion | GO:0046686 | 8 | 0.022 | |
| insulin processing | GO:0030070 | 2 | 0.021 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.021 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.021 | |
| positive regulation of systemic arterial blood pressure | GO:0003084 | 9 | 0.021 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.021 | |
| retinoid metabolic process | GO:0001523 | 24 | 0.021 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.021 | |
| foregut regionalization | GO:0060423 | 3 | 0.021 | |
| positive regulation of growth | GO:0045927 | 104 | 0.021 | |
| camera type eye development | GO:0043010 | 266 | 0.021 | |
| regulation of ion transport | GO:0043269 | 215 | 0.020 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.020 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.020 | |
| appendage development | GO:0048736 | 166 | 0.020 | |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.020 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.020 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.020 | |
| tissue migration | GO:0090130 | 68 | 0.020 | |
| forebrain development | GO:0030900 | 302 | 0.020 | |
| protein activation cascade | GO:0072376 | 19 | 0.020 | |
| toxin metabolic process | GO:0009404 | 5 | 0.019 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.019 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.019 | |
| cellular glucan metabolic process | GO:0006073 | 32 | 0.019 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.019 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.019 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.019 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.019 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.019 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.019 | |
| regulation of tyrosine phosphorylation of stat1 protein | GO:0042510 | 2 | 0.019 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.019 | |
| positive regulation of protein kinase c activity | GO:1900020 | 1 | 0.019 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.019 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.019 | |
| female gamete generation | GO:0007292 | 74 | 0.019 | |
| negative regulation of peptide secretion | GO:0002792 | 16 | 0.018 | |
| response to alkaloid | GO:0043279 | 34 | 0.018 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.018 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.018 | |
| glucose transport | GO:0015758 | 56 | 0.018 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.018 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.018 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.018 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.018 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.018 | |
| endocrine hormone secretion | GO:0060986 | 15 | 0.018 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.018 | |
| amino acid transmembrane transport | GO:0003333 | 37 | 0.018 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.018 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.018 | |
| photoreceptor cell development | GO:0042461 | 40 | 0.018 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.018 | |
| epithelial cell migration | GO:0010631 | 63 | 0.018 | |
| fertilization | GO:0009566 | 127 | 0.018 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.018 | |
| eye photoreceptor cell differentiation | GO:0001754 | 41 | 0.018 | |
| gonad development | GO:0008406 | 141 | 0.018 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.018 | |
| maintenance of location | GO:0051235 | 89 | 0.018 | |
| organelle localization | GO:0051640 | 179 | 0.017 | |
| negative regulation of cellular response to insulin stimulus | GO:1900077 | 16 | 0.017 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.017 | |
| biomineral tissue development | GO:0031214 | 64 | 0.017 | |
| vasoconstriction | GO:0042310 | 27 | 0.017 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.017 | |
| somatotropin secreting cell development | GO:0060133 | 2 | 0.017 | |
| secondary metabolic process | GO:0019748 | 18 | 0.017 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.017 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.017 | |
| hair follicle development | GO:0001942 | 85 | 0.017 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.017 | |
| phosphatidylinositol 3 kinase signaling | GO:0014065 | 36 | 0.017 | |
| adiponectin activated signaling pathway | GO:0033211 | 4 | 0.017 | |
| regulation of cell motility | GO:2000145 | 236 | 0.017 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.016 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.016 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.016 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.016 | |
| endothelial cell migration | GO:0043542 | 44 | 0.016 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.016 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.016 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.016 | |
| limb development | GO:0060173 | 166 | 0.016 | |
| transition metal ion transport | GO:0000041 | 38 | 0.016 | Mouse |
| renal system process involved in regulation of systemic arterial blood pressure | GO:0003071 | 15 | 0.016 | |
| endothelium development | GO:0003158 | 45 | 0.016 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.016 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.016 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.016 | |
| organelle fission | GO:0048285 | 170 | 0.016 | |
| calcium ion transport | GO:0006816 | 159 | 0.016 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.016 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.016 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.016 | |
| hemostasis | GO:0007599 | 78 | 0.016 | |
| acyl coa metabolic process | GO:0006637 | 19 | 0.016 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.016 | |
| developmental maturation | GO:0021700 | 193 | 0.016 | |
| response to iron ion | GO:0010039 | 4 | 0.016 | |
| rhythmic process | GO:0048511 | 174 | 0.015 | |
| interleukin 8 production | GO:0032637 | 4 | 0.015 | |
| regulation of binding | GO:0051098 | 111 | 0.015 | |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.015 | |
| neuronal action potential | GO:0019228 | 54 | 0.015 | |
| intestinal absorption | GO:0050892 | 13 | 0.015 | |
| cell junction organization | GO:0034330 | 77 | 0.015 | |
| extracellular structure organization | GO:0043062 | 148 | 0.015 | |
| 9 cis retinoic acid metabolic process | GO:0042905 | 5 | 0.015 | |
| regulation of cell activation | GO:0050865 | 289 | 0.015 | |
| glucocorticoid metabolic process | GO:0008211 | 9 | 0.015 | |
| positive regulation of phosphatidylinositol 3 kinase signaling | GO:0014068 | 20 | 0.015 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.015 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.015 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.015 | |
| male gamete generation | GO:0048232 | 285 | 0.015 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.015 | |
| regulation of gluconeogenesis | GO:0006111 | 30 | 0.015 | |
| positive regulation of cholesterol biosynthetic process | GO:0045542 | 3 | 0.015 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.015 | |
| positive regulation of fatty acid metabolic process | GO:0045923 | 8 | 0.015 | |
| endocytosis | GO:0006897 | 168 | 0.015 | |
| cytokine production | GO:0001816 | 319 | 0.015 | Mouse |
| epithelial cell development | GO:0002064 | 159 | 0.015 | |
| astrocyte activation | GO:0048143 | 2 | 0.015 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.015 | |
| triglyceride rich lipoprotein particle remodeling | GO:0034370 | 2 | 0.015 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.015 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.015 | |
| acetylcholine catabolic process | GO:0006581 | 1 | 0.015 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.015 | |
| regulation of defense response | GO:0031347 | 233 | 0.014 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.014 | |
| positive regulation of protein activation cascade | GO:2000259 | 2 | 0.014 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.014 | |
| positive regulation of fatty acid biosynthetic process | GO:0045723 | 3 | 0.014 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.014 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.014 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.014 | |
| very low density lipoprotein particle remodeling | GO:0034372 | 1 | 0.014 | |
| neuron death | GO:0070997 | 154 | 0.014 | |
| regulation of plasminogen activation | GO:0010755 | 4 | 0.014 | |
| response to oxygen levels | GO:0070482 | 62 | 0.014 | |
| regulation of urea metabolic process | GO:0034255 | 1 | 0.014 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.014 | |
| response to bile acid | GO:1903412 | 1 | 0.014 | |
| peptide secretion | GO:0002790 | 114 | 0.014 | |
| protein lipid complex subunit organization | GO:0071825 | 12 | 0.014 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.014 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.014 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.014 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.014 | |
| spermatogenesis | GO:0007283 | 284 | 0.014 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.014 | |
| regulation of ammonia assimilation cycle | GO:2001248 | 1 | 0.014 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.014 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.014 | |
| skin development | GO:0043588 | 220 | 0.013 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.013 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.013 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.013 | Mouse |
| cholesterol biosynthetic process | GO:0006695 | 15 | 0.013 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.013 | |
| regulation of cellular response to insulin stimulus | GO:1900076 | 30 | 0.013 | |
| potassium ion transport | GO:0006813 | 52 | 0.013 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.013 | |
| regulation of steroid biosynthetic process | GO:0050810 | 26 | 0.013 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.013 | |
| steroid hormone secretion | GO:0035929 | 9 | 0.013 | |
| response to testosterone | GO:0033574 | 3 | 0.013 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.013 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.013 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.013 | |
| glial cell differentiation | GO:0010001 | 131 | 0.013 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.013 | |
| ammonia assimilation cycle | GO:0019676 | 2 | 0.013 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.013 | |
| response to osmotic stress | GO:0006970 | 21 | 0.013 | |
| triglyceride mobilization | GO:0006642 | 5 | 0.013 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.013 | |
| molting cycle | GO:0042303 | 90 | 0.013 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.013 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.013 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.013 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.013 | |
| renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure | GO:0003072 | 5 | 0.013 | |
| cholesterol storage | GO:0010878 | 4 | 0.013 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.013 | |
